Trial
NCT04204122
Vigamox Treatment for Ocular Graft-Versus-Host Disease
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Washington University School of Medicine
Collaborators
—
Condition
Ocular Graft-versus-host Disease
Intervention
Vigamox
Why stopped
Investigator decided to close study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-08